Find Research outputs

Search results

• Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms

  Kase, Y. & Okano, H., 12-2021, In: Inflammation and Regeneration. 41, 1, 15.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
  13 Citations (Scopus)

• Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection

  Keio Donner Project, 01-2021, In: Journal of Hospital Infection. 107, p. 40-44 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  19 Citations (Scopus)

• Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation

  Nishitsuji, H., Iwahori, S., Ohmori, M., Shimotohno, K. & Murata, T., 08-2022, In: mBio. 13, 4

  Research output: Contribution to journal › Article › peer-review

  Open Access
  36 Citations (Scopus)

• Coronavirus Disease 19 (COVID-19) Vaccine Effectiveness Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection during Delta-Dominant and Omicron-Dominant Periods in Japan: A Multicenter Prospective Case-control Study (Factors Associated with SARS-CoV-2 Infection and the Effectiveness of COVID-19 Vaccines Study)

  Arashiro, T., Arima, Y., Muraoka, H., Sato, A., Oba, K., Uehara, Y., Arioka, H., Yanai, H., Kuramochi, J., Ihara, G., Chubachi, K., Yanagisawa, N., Nagura, Y., Kato, Y., Ueda, A., Numata, A., Kato, H., Ishii, K., Ooki, T. & Oka, H. & 6 others, Nishida, Y., Stucky, A., Smith, C., Hibberd, M., Ariyoshi, K. & Suzuki, M., 01-02-2023, In: Clinical Infectious Diseases. 76, 3, p. E108-E115

  Research output: Contribution to journal › Article › peer-review
  44 Citations (Scopus)

• Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CL^pro detected in the SCORPIO-SR phase 3 trial

  Uehara, T., Yotsuyanagi, H., Ohmagari, N., Doi, Y., Yamato, M., Imamura, T., Sakaguchi, H., Fukushi, A., Takeda, Y., Baba, K., Nobori, H., Miyamoto, T., Arita, S., Dodo, R., Shimba, A., Fukao, K., Shishido, T., Tsuge, Y. & Mukae, H., 04-2025, In: Antiviral Research. 236, 106097.

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Temporal patterns of asymptomatic SARS-CoV-2 infection among pediatric population in Japan: A 3-year analysis

  Kozawa, K., Higashimoto, Y., Kawamura, Y., Miura, H., Hattori, F., Mihara, Y., Nakai, H., Nishimura, N., Ozaki, T., Ihira, M. & Yoshikawa, T., 08-2024, In: Journal of Medical Virology. 96, 8, e29847.

  Research output: Contribution to journal › Article › peer-review

• A phase 2/3 study of S-217622 in participants with SARS-CoV-2 infection (Phase 3 part)

  Yotsuyanagi, H., Ohmagari, N., Doi, Y., Imamura, T., Sonoyama, T., Ichihashi, G., Sanaki, T., Tsuge, Y., Uehara, T. & Mukae, H., 22-02-2023, In: Medicine (United States). 102, 8, p. E33024

  Research output: Contribution to journal › Article › peer-review

  Open Access
  37 Citations (Scopus)

• Comparative analysis of antigen-specific anti-SARS-CoV-2 antibody isotypes in COVID-19 patients

  Fujigaki, H., Inaba, M., Osawa, M., Moriyama, S., Takahashi, Y., Suzuki, T., Yamase, K., Yoshida, Y., Yagura, Y., Oyamada, T., Takemura, M., Doi, Y. & Saito, K., 15-05-2021, In: Journal of Immunology. 206, 10, p. 2393-2401 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  20 Citations (Scopus)

• Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan

  Arashiro, T., Arima, Y., Kuramochi, J., Muraoka, H., Sato, A., Chubachi, K., Yanai, A., Arioka, H., Uehara, Y., Ihara, G., Kato, Y., Yanagisawa, N., Ueda, A., Kato, H., Oka, H., Nishida, Y., Nidaira, Y., Asami, T., Jinta, T. & Nakamura, A. & 12 others, Oba, K., Taniyama, D., Yamamoto, K., Tanaka, K., Ueshima, K., Fuwa, T., Stucky, A., Suzuki, T., Smith, C., Hibberd, M., Ariyoshi, K. & Suzuki, M., 01-06-2023, In: Open Forum Infectious Diseases. 10, 6, ofad240.

  Research output: Contribution to journal › Article › peer-review
  12 Citations (Scopus)

• A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine EXG-5003 against SARS-CoV-2

  Koseki, T., Teramachi, M., Koga, M., Ko, M. S. H., Amano, T., Yu, H., Amano, M., Leyder, E., Badiola, M., Ray, P., Kim, J., Ko, A. C., Achour, A., Weng, N. P., Imai, T., Yoshida, H., Taniuchi, S., Shintani, A., Fujigaki, H. & Kondo, M. & 1 others, Doi, Y., 12-2023, In: Vaccines. 11, 12, 1767.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  5 Citations (Scopus)

• Breakthrough infections of e484k-harboring sars-cov-2 delta variant, lombardy, italy more articles on coronavirus, covid-19

  Doi, Y., Ishii, K., Nishizono, A., Nanbo, A., Urata, S., Kurane, I., Celebrado, J. C., Depatillo, J. P., Bandola, Z., Griffin, D. E., Park, E. C., McDonald, D., Lu, K., Gayle Bernabe, K. & Handley, G., 10-2021, In: Emerging Infectious Diseases. 27, 10

  Research output: Contribution to journal › Article › peer-review

  Open Access

• Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2

  Nakagawa, M., Fujishiro, Y., Doi, Y., Yamakami, J. & Honda, H., 01-07-2024, In: Infection Control and Hospital Epidemiology. 45, 7, p. 903-905 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures

  Kase, Y., Sonn, I., Goto, M., Murakami, R., Sato, T. & Okano, H., 05-2023, In: Experimental Neurology. 363, 114379.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  18 Citations (Scopus)

• Reliability of serological tests for COVID-19: comparison of three immunochromatography test kits for SARS-CoV-2 antibodies

  Fujigaki, H., Takemura, M., Osawa, M., Sakurai, A., Nakamoto, K., Seto, K., Fujita, T., Hata, T., Akiyama, H., Doi, Y. & Saito, K., 09-2020, In: Heliyon. 6, 9, e04929.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  14 Citations (Scopus)

• Behavioral factors associated with SARS-CoV-2 infection in Japan

  Arashiro, T., Arima, Y., Muraoka, H., Sato, A., Oba, K., Uehara, Y., Arioka, H., Yanai, H., Yanagisawa, N., Nagura, Y., Kato, Y., Kato, H., Ueda, A., Ishii, K., Ooki, T., Oka, H., Nishida, Y., Stucky, A., Miyahara, R. & Smith, C. & 3 others, Hibberd, M., Ariyoshi, K. & Suzuki, M., 09-2022, In: Influenza and other Respiratory Viruses. 16, 5, p. 952-961 10 p.

  Research output: Contribution to journal › Article › peer-review
  14 Citations (Scopus)

• Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2

  Fujigaki, H., Yamamoto, Y., Koseki, T., Banno, S., Ando, T., Ito, H., Fujita, T., Naruse, H., Hata, T., Moriyama, S., Takahashi, Y., Suzuki, T., Murakami, T., Yoshida, Y., Yagura, Y., Oyamada, T., Takemura, M., Kondo, M., Iwata, M. & Saito, K., 02-2022, In: Microbiology spectrum. 10, 1, e01181-21.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  21 Citations (Scopus)

• Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers

  Murata, T., Sakurai, A., Suzuki, M., Komoto, S., Ide, T., Ishihara, T. & Doi, Y., 05-2021, In: mSphere. 6, 3, p. 1-7 7 p., e00019-21.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  25 Citations (Scopus)

• A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part

  Mukae, H., Yotsuyanagi, H., Ohmagari, N., Doi, Y., Imamura, T., Sonoyama, T., Fukuhara, T., Ichihashi, G., Sanaki, T., Baba, K., Takeda, Y., Tsuge, Y. & Uehara, T., 10-2022, In: Antimicrobial agents and chemotherapy. 66, 10

  Research output: Contribution to journal › Article › peer-review

  Open Access
  87 Citations (Scopus)

• Immune response against SARS-CoV-2 in pediatric patients including young infants

  Kawamura, Y., Higashimoto, Y., Miura, H., Ihira, M., Inaba, M., Ito, R., Kozawa, K. & Yoshikawa, T., 03-2021, In: Journal of Medical Virology. 93, 3, p. 1776-1779 4 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Natural History of Asymptomatic SARS-CoV-2 Infection

  Sakurai, A., Sasaki, T., Kato, S., Hayashi, M., Tsuzuki, S. I., Ishihara, T., Iwata, M., Morise, Z. & Doi, Y., 27-08-2020, In: New England Journal of Medicine. 383, 9

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  211 Citations (Scopus)

• Pro108Ser mutation of SARS-CoV-2 3CL^pro reduces the enzyme activity and ameliorates the clinical severity of COVID-19

  Keio Donner Project, 12-2022, In: Scientific reports. 12, 1, 1299.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  17 Citations (Scopus)

• Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2–induced lung exudative vasculitis and predicts COVID-19 severity

  Iwamura, C., Hirahara, K., Kiuchi, M., Ikehara, S., Azuma, K., Shimada, T., Kuriyama, S., Ohki, S., Yamamoto, E., Inaba, Y., Shiko, Y., Aoki, A., Kokubo, K., Hirasawa, R., Hishiya, T., Tsuji, K., Nagaoka, T., Ishikawa, S., Kojima, A. & Mito, H. & 29 others, Hase, R., Kasahara, Y., Kuriyama, N., Tsukamoto, T., Nakamura, S., Urushibara, T., Kaneda, S., Sakao, S., Tobiume, M., Suzuki, Y., Tsujiwaki, M., Kubo, T., Hasegawa, T., Nakase, H., Nishida, O., Takahashi, K., Baba, K., Iizumi, Y., Okazaki, T., Kimura, M. Y., Yoshino, I., Igari, H., Nakajima, H., Suzuki, T., Hanaoka, H., Nakada, T. A., Ikehara, Y., Yokote, K. & Nakayama, T., 16-08-2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 33, e2203437119.

  Research output: Contribution to journal › Article › peer-review
  17 Citations (Scopus)

• Expected immune recognition of COVID-19 virus by memory from earlier infections with common coronaviruses in a large part of the world population

  Dijkstra, J. M. & Hashimoto, K., 2020, In: F1000Research. 9, 285.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  16 Citations (Scopus)

• Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal models

  Takeshita, M., Fukuyama, H., Kamada, K., Matsumoto, T., Makino-Okamura, C., Uchikubo-Kamo, T., Tomabechi, Y., Hanada, K., Moriyama, S., Takahashi, Y., Ishigaki, H., Nakayama, M., Nguyen, C. T., Kitagawa, Y., Itoh, Y., Imai, M., Maemura, T., Furusawa, Y., Ueki, H. & Iwatsuki-Horimoto, K. & 11 others, Ito, M., Yamayoshi, S., Kawaoka, Y., Shirouzu, M., Ishii, M., Saya, H., Kondo, Y., Kaneko, Y., Suzuki, K., Fukunaga, K. & Takeuchi, T., 22-12-2022, In: iScience. 25, 12, 105596.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  10 Citations (Scopus)

• Immune evasion and chronological decrease in titer of neutralizing antibody against SARS-CoV-2 and its variants of concerns in COVID-19 patients

  for the Keio Donner Project, 05-2022, In: Clinical Immunology. 238, 108999.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  9 Citations (Scopus)